East Brunswick, NJ, United States of America

Salvatore J Siciliano

This inventor holds 2 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 1997-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Salvatore J Siciliano. Retrieved from https://idiyas.com/inventor/salvatore-j-siciliano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1997-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Salvatore J Siciliano: Innovator in Biochemical Research

Introduction

Salvatore J Siciliano is a notable inventor based in East Brunswick, NJ (US). He has made significant contributions to the field of biochemical research, particularly in the development of assays and receptors that have potential therapeutic applications. With a total of 2 patents, his work is recognized for its impact on understanding and treating various medical conditions.

Latest Patents

One of his latest patents is related to the eosinophil eotaxin receptor. This receptor has been isolated, cloned, and sequenced, and is classified as a human β-chemokine receptor designated as “CC CKR3.” The eosinophil eotaxin receptor can be utilized to screen and identify compounds that bind to it, which may be beneficial in treating and preventing atopic conditions such as allergic rhinitis, dermatitis, conjunctivitis, and particularly bronchial asthma.

Another significant patent involves an assay designed to identify human C5a antagonists and agonists. This invention includes a series of peptides that facilitate the screening for inhibitors of C5a binding, specifically targeting the subsite on the C5a receptor occupied by the C-terminus of C5a. The peptides developed have a much greater affinity (Ki<10 nM) compared to the natural C-terminus of C5a (Ki=300 µM). This invention is instrumental in developing agonists, partial agonists, and antagonists of C5a, along with methods for their use.

Career Highlights

Salvatore J Siciliano is currently associated with Merck & Co., Inc., where he continues to contribute to innovative research in the pharmaceutical industry. His work has been pivotal in advancing the understanding of various biochemical pathways and their implications in health and disease.

Collaborations

Throughout his career, Salvatore has collaborated with esteemed colleagues, including Martin S Springer and Zenon D Konteatis. These collaborations have further enriched his research and contributed to the successful development of his patented inventions.

Conclusion

Salvatore J Siciliano's contributions to biochemical research through his patents and collaborations highlight his role as an innovator in the field. His work not only advances scientific knowledge but also holds promise for improving therapeutic strategies for various medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…